Karius is a Biotech company based in Palo Alto, California. It has raised $355M in total funding. Latest round: Series C.
Karius funding overview
Karius is a Biotech company based in Palo Alto, California. Karius has raised $355M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series C. Investors on record include Khosla Ventures, 5AM Ventures, Gilde Healthcare, Seventure Partners, SoftBank Investment Advisers, General Catalyst and 6 others. 12 distinct backers are named across the disclosed rounds.
Karius at a glance
Total raised
$355M
Latest round
Series C
Industry
Biotech
Headquarters
Palo Alto, California
Notable investors
Khosla Ventures, 5AM Ventures, Gilde Healthcare, Seventure Partners, SoftBank Investment Advisers, General Catalyst, HBM Healthcare Investments, Blue Water Life Sciences
Frequently asked about Karius funding
How much has Karius raised?
Karius has raised $355M in total disclosed funding across the rounds on record.
Who has invested in Karius?
Khosla Ventures, 5AM Ventures, Gilde Healthcare, Seventure Partners, SoftBank Investment Advisers, General Catalyst are named among the investors backing Karius.
What was the latest Karius funding round?
The most recent disclosed round is a Series C.
Where is Karius based?
Karius is based in Palo Alto, California.
What sector does Karius operate in?
Karius is tracked under Biotech from Palo Alto, California, with $355M in disclosed funding.
Karius totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Palo Alto below to benchmark round size and investor mix.
